Dr Reddys Laboratories Ltd Share Price Today - Live Blog for April 11, 2026

Dr Reddys Laboratories Ltd's stock has risen by a substantial 1.68%, and as of now, it's trading at 1232.20 per share. This upward trajectory is attracting keen interest from investors.

After a notable 1.68% increase, Dr Reddys Laboratories Ltd's shares are now trading at 1232.20. This surge signifies heightened investor interest in acquiring the stock. The stock has a debt to equity ratio of 0.1625 and an ROE of 16.0277.

Climbing steadily, Dr Reddys Laboratories Ltd shares have ascended by 1.68%, reaching the current market price of 1232.20. This ascent signifies increased investor sentiment. The stock has an ROE of 16.0277 and debt to equity ratio of 0.1625.

Dr Reddys Laboratories Ltd's share price rallied by 1.68%, reaching the current market price of 1232.20. This surge is indicative of the stock's recent positive performance.

The share price of Dr Reddys Laboratories Ltd soared by an impressive 1.68%, marking a substantial gain for investors. At present, this stock can be acquired at a current market price of 1232.20 per share.

Demonstrating a commendable 1.68% gain, Dr Reddys Laboratories Ltd's share price is currently situated at 1232.20. In terms of valuation, the stock maintains a PE ratio of 18.6200, while the industry PE ratio stands at 31.9052.

In a noteworthy development, Dr Reddys Laboratories Ltd witnessed a remarkable 1.68% increase in its share price. This surge in value has sparked heightened investor interest, with the stock currently trading at 1232.20 per share. The stock has an ROE of 16.0277 and debt to equity ratio of 0.1625.

Dr Reddys Laboratories Ltd experienced a substantial 1.68% boost in its share price and has garnered significant attention from the market. It's now trading at 1232.20, making it an appealing option for investors.

After a notable 1.68% increase, Dr Reddys Laboratories Ltd's shares are now trading at 1232.20. This surge signifies heightened investor interest in acquiring the stock. The stock has a debt to equity ratio of 0.1625 and an ROE of 16.0277.

With a remarkable 1.68% increase in value, the share price of Dr Reddys Laboratories Ltd currently stands at 1232.20. Notably, this stock has a Price-to-Earnings (PE) ratio of 18.6200, while the industry's PE ratio is 31.9052.

Dr Reddys Laboratories Ltd has had quite the run lately, experiencing a substantial 1.68% uptick in its share price. As a result, it's now actively trading at 1232.20 per share, making it an attractive option for investors.